ERITROCITOSIS TRATAMIENTO PDF

ERITROCITOSIS PATOLÓGICA DE ALTURA: Caracterización biológica, diagnóstico y tratamiento. HIGH ALTITUDE PATHOLOGICAL ERYTHROCYTOSIS. Diagnóstico y tratamiento | 23 DIC Eritrocitosis. Actualización de los métodos diagnósticos y el manejo de los pacientes con eritrocitosis. 3. original research. DOI: Secondary erythrocytosis due to hypoxemia as prognosis. in exacerbated chronic .

Author: Gardataxe Fenrigor
Country: Ukraine
Language: English (Spanish)
Genre: Art
Published (Last): 1 May 2014
Pages: 393
PDF File Size: 15.21 Mb
ePub File Size: 19.48 Mb
ISBN: 447-4-97127-407-3
Downloads: 60778
Price: Free* [*Free Regsitration Required]
Uploader: Yomi

The prognostic value of this variable in the exacerbation has not been evaluated to date. The variables that were statistically significant showed some unusual associations, particularly with the Anthonisen classification and the presence of a history of heart failure, the latter being a protective factor, without defining a coherent explanation for this finding and without any publication report with a similar result that could be used to infer that protective effect.

There are limited data on its usefulness, as there are no works on proper methodology to evaluate its effectiveness Multivariate analysis of prognostic factors for the composite outcome. Type chronic lung disease.

Eritrocitosis – Artículos – IntraMed

While the minority of patients had a severe functional class IVthe use of long-acting bronchodilators was limited to only five cases, compared with the more extensive use of methylxanthines.

Determining which patients had chronic hypoxemia at admission was difficult because, in most cases, there were no data, and for those who received home oxygen its indication tratamiwnto unknown.

Use of systemic steroids. Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Haemoglobin level and its clinical impact in a cohort of patients with COPD.

In addition, the distribution of variables was stratified by sex and hematocrit value, which was categorized into three groups according to the 25th and 75th percentiles of the distribution. Conflict of interests None stated by the authors. Hematocrit and the risk of cardiovascular disease—the Framingham study: Efficacy and safety of low-dose aspirin in polycythemia vera.

  DOWER EMBRACING DEFEAT PDF

There are several observations that have found a worse prognosis of mortality and need for hospitalization in patients with lower red cell mass compared to those with higher values eritrocltosis, Discussion This study attempted to establish the relationship between red blood cell parameters and the development of adverse outcomes at 30 days in patients with exacerbated chronic lung disease.

Patients over 18 years of age, with a history of chronic lung disease, hypoxemia at admission and diagnostic impression of exacerbation of, infectious or non-infectious, chronic lung disease were selected.

After checking the study entry criteria and obtaining the authorization of the patients or caregiver for inclusion, we proceeded to collect information through a survey to patients during their hospital stay. Transfer to intensive care unit. During hospital stay, eight cases presented complications, four of them showed one of the eritroictosis assessed at 30 days, and only one included death.

Int Med J ; Adverse outcomes were more likely to occur at the extremes of the distribution of hematocrit values, also with longer hospital etitrocitosis when hematocrit values were lower. Epidemiology of myeloproliferative neoplasms in the United States. Hemorheology in the erythrocytoses.

Spleen sizing by ultrasound in polycythaemia and thrombocythaemia: The frequency of anemia was 7. For bivariate analysis, the Mann-Whitney U test was performed.

Revista de la Facultad de Medicina

Effects of erythrapheresis on pulmonary haemodynamics and oxygen transport in patients with secondary polycythaemia and cor pulmonale. Domiciliary oxygen for chronic obstructive pulmonary disease. Am J Hematol ; The outcome variable was a composite between death, length of hospital stay in floors, need for invasive or non-invasive ventilatory support, need to transfer to ICU and eritrocitoss, provided that they were associated with chronic lung disease.

  AIPHONE JA-DAC PDF

Regarding the outcomes, there was a predilection to higher length hospital stay in the presence of lower levels of hematocrit. Br Erirrocitosis Dis Chest ; Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: Asthma cases had an exclusive distribution in women.

INADEQUATE TREATMENT OF EXCESSIVE ERYTHROCYTOSIS

To establish the association between the independent qualitative variables and the dependent or outcome variable, the Chi square test of independence X 2 was used along with the Mantel-Haenszel method. Effects of long-term oxygen therapy on mortality and morbidity. Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: On the other hand, the presence of the exacerbation did not differ according to the Anthonisen criteria, but did show a trend to greater affectation of oxygenation and hypercapnia in the presence of higher hematocrit levels.

Erythrocytosis frequency was Chronic obstructive pulmonary disease exacerbations in emergency departments: Cardiovascular events and intensity of treatment in polycythemia vera. Determining the virtual implications of red cell parameters in patients with pulmonary exacerbations could help defining the particular use of measures such as phlebotomy or red blood cell transfusion. Acute leukemia and myelodysplasia in patients with a Philadelphia chromosome negative chronic myeloproliferative disorder treated with hydroxyurea alone or with hydroxyurea after busulphan.